Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

A medication for skin rash also unexpectedly treated hair loss in a patient.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Tislelizumab can cause cutaneous lupus erythematosus.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Apremilast may help treat hair loss in alopecia areata.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Baricitinib is the most effective treatment for alopecia areata.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Baricitinib was effective in treating both early and late onset alopecia areata.